Policy / Regulatory

NHSA Clears Retagliptin and Ambroxol for National Reimbursement Drug List Inclusion

CompanyDrug

FDA Grants Priority Review to MSD’s Welireg for Advanced RCC Indication Extension

CompanyDeals

Kangtai Biological Expands Global Reach with Varicella Vaccine Licensing Deals

CompanyDrug

Astellas Pharma’s Xtandi NDA for mHSPC Treatment Accepted by China’s CDE

CompanyDrug

Pfizer’s Litfulo Earns EU Approval as First Treatment for Severe Alopecia Areata in Teens

CompanyDeals

Tianjin Century Kangtai Biomedical Raises Hundreds of Millions in Series A+ and B Financings

CompanyDrug

Walvax Biotechnology Receives Indonesian FDA Approval for Phase III Pneumococcal Vaccine Trial

CompanyDrug

Sunshine Guojian Pharmaceutical Gets NMPA Approval for SSGJ-611 Phase II COPD Study

CompanyDrug

AbbVie’s Allergan Aesthetics Secures NMPA Approval for Juvéderm VOLUMA with Lidocaine

CompanyDeals

Northeast Pharmaceutical Partners with Muscat Changming for Middle East Expansion

CompanyDeals

Cure Genetics and Frametact Ltd Partner on AAV Vectors for Neurological Diseases

CompanyDrug

Caliway Biopharmaceuticals’ CBL-514 Achieves Milestones in Dercum’s Disease Trial